Pulmonary hypertension in chronic obstructive pulmonary disease: current understanding, knowledge gaps and future directions
WT Atchley, TK Kakkera - Current Opinion in Pulmonary Medicine, 2024 - journals.lww.com
As the PAH population-base ages and comorbid diseases become more frequently
diagnosed in PAH patients, the need to clearly delineate subpopulations for clinical …
diagnosed in PAH patients, the need to clearly delineate subpopulations for clinical …
Predictors of Mortality in Pulmonary Hypertension-Associated Chronic Lung Disease
J Pescatore, M Bittner, G D'Alonzo, S Weaver… - Journal of Clinical …, 2024 - mdpi.com
Background/Objectives: Pulmonary hypertension (PH) often accompanies chronic lung
diseases. Several chronic lung diseases with PH portends unfavorable outcomes. We …
diseases. Several chronic lung diseases with PH portends unfavorable outcomes. We …
Prediction of clinical risk assessment and survival in chronic obstructive pulmonary disease with pulmonary hypertension
D Zhou, C Liu, L Wang, JF Li, Y Zhao… - Clinical and …, 2024 - Wiley Online Library
Background Patients with pulmonary hypertension (PH) and chronic obstructive pulmonary
disease (COPD) have an increased risk of disease exacerbation and decreased survival …
disease (COPD) have an increased risk of disease exacerbation and decreased survival …
[HTML][HTML] Ten-year analysis of the efficacy of vaccination against pneumococcal infection in patients with chronic obstructive pulmonary disease
GL Ignatova, SN Avdeev, VN Antonov… - …, 2023 - journal.pulmonology.ru
Major problems in the course of chronic obstructive pulmonary disease (COPD) include
frequent exacerbations and related deaths. The use of pneumococcal vaccines, primarily a …
frequent exacerbations and related deaths. The use of pneumococcal vaccines, primarily a …
Diagnostic value of combined FVC%/DLCO% and echocardiography in connective tissue disorder‑associated pulmonary hypertension
H Shi, P Gao, H Liu, J Su, X He - Medicine …, 2024 - spandidos-publications.com
The main objective of the present study was to investigate whether forced vital capacity
(FVC)%/diffusing capacity of the lungs for carbon monoxide (DLCO)% can be used to predict …
(FVC)%/diffusing capacity of the lungs for carbon monoxide (DLCO)% can be used to predict …
Десятилетний анализ эффективности вакцинации против пневмококковой инфекции у пациентов с хронической обструктивной болезнью легких
ГЛ Игнатова, СН Авдеев, ВН Антонов… - …, 2023 - journal.pulmonology.ru
Аннотация Одна из основных проблем течения хронической обструктивной болезни
легких (ХОБЛ)–частые обострения и связанные с ними случаи смерти …
легких (ХОБЛ)–частые обострения и связанные с ними случаи смерти …
[PDF][PDF] 12Enfermedad pulmonar
L Torre-Bouscoulet - mendezeditores.com.mx
Se espera que la prevalencia de EPOC siga en ascenso en los próximos años debido a la
continua exposición a factores de riesgo y al envejecimiento de la población. A nivel global …
continua exposición a factores de riesgo y al envejecimiento de la población. A nivel global …